腰椎椎间融合愈合过程中骨代谢标志物的时间变化
这项前瞻性纵向研究纳入78例无骨质疏松的腰椎椎间融合患者,监测骨形成标志物BAP、P1NP、OC和骨吸收标志物TRACP-5b在术后52周内的变化。融合组中BAP和P1NP于术后4周达峰,TRACP-5b和OC于8周达峰,BAP持续升高至52周;骨不连组峰值显著更高且BAP、P1NP升高持续至52周。
要点
- 无骨质疏松患者腰椎融合后骨转换标志物呈先降后升的时序变化,BAP和P1NP于4周达峰,TRACP-5b和OC于8周达峰。
- 融合组BAP持续高于基线至术后52周,P1NP和TRACP-5b在一年内逐渐回落至基线附近。
- 骨不连组骨转换标志物峰值显著高于融合组,且BAP和P1NP升高持续至52周。
核心结论
- 无骨质疏松患者腰椎融合后骨转换标志物呈现可预测的时序变化,骨不连者峰值更高且升高持续更久。
研究设计与样本
- 前瞻性纵向研究,纳入78例接受一或两节段经椎间孔腰椎椎间融合术的无骨质疏松患者。
主要发现
- 78例中71例(91%)达到坚固融合,7例发生骨不连。
- 融合组术后1周所有骨转换标志物均下降,BAP和P1NP于4周达峰,TRACP-5b和OC于8周达峰。
- 融合组P1NP和TRACP-5b在一年内逐渐接近基线,BAP维持高位至术后52周。
- 骨不连组骨转换标志物峰值显著高于融合组,BAP和P1NP升高持续至52周。
关键数值与推荐
- 融合状态通过CT矢状面和冠状面图像评估。
- 骨形成标志物包括BAP、P1NP和OC,骨吸收标志物为TRACP-5b。
- 血清样本采集时间点为术前及术后1、2、4、8、13、26、39、52周。
临床怎么用
- 骨转换标志物可作为无骨质疏松患者腰椎融合术后骨愈合的动态监测工具,辅助解读融合进程。
- BAP和P1NP持续升高至52周可能提示骨不连风险,需结合影像学进一步评估。
局限性
- 研究仅纳入无骨质疏松患者,结论不适用于骨质疏松人群。
- 样本量有限,骨不连组仅7例,组间比较需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Prospective longitudinal study. OBJECTIVE: The aim of this study was to evaluate temporal changes of bone turnover markers (BTMs) after lumbar spinal fusion in patients without osteoporosis. SUMMARY OF BACKGROUND DATA: Radiological studies are the standard method to monitor bony fusion, but they do not allow a timely assessment of bone healing. BTMs react rapidly to changes in bone metabolism during fusion process and could be an additional tool to monitor this process. METHODS: A total of 78 nonosteoporosis patients who had undergone one- or two-level transforaminal lumbar interbody fusion were included. Fusion status was assessed using computed tomography sagittal and coronal images. Serum levels of bone-specific alkaline phosphatase (BAP), procollagen type 1 amino-terminal propeptide (P1NP), and osteocalcin (OC) were measured to assess bone formation, and tartrate-resistant acid phosphatase 5b (TRACP-5b) was measured to assess bone resorption. Serum samples were obtained before surgery and at 1, 2, 4, 8, 13, 26, 39, and 52 weeks after surgery. RESULTS: A solid fusion was achieved in 71 of 78 patients (91%), and seven patients resulted in pseudarthrosis. In the fusion group, the level of all BTMs once decreased at 1 postoperative week. Then, BAP and P1NP reached a peak at 4 weeks after surgery, and TRACP-5b and OC peaked at 8 weeks. Thereafter, the level of P1NP and TRACP-5b gradually got closer to the baseline over a year, and BAP kept high until 52 postoperative weeks. In the pseudarthrosis group, peak level of BTMs was significantly higher and the increased level of BAP and P1NP was kept until 52 weeks. CONCLUSION: The present study demonstrated dynamics of BTMs after lumbar spinal fusion in patients without osteoporosis. These normal population data contribute as a baseline to evaluate the effect of osteogenic agents on bone metabolism after spinal fusion.Level of Evidence: 2.
引用
- Hyakkan R, Kanayama M, Takahata M, et al. Bone Metabolism in the Healing Process of Lumbar Interbody Fusion: Temporal Changes of Bone Turnover Markers. Spine (Phila Pa 1976). 2021. PMID: 33882539. doi:10.1097/BRS.0000000000004075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。